BlackRock Investment Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

BlackRock Investment Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-35,540	Closed	-$1.41M	–	4029
2016 Q3	$1.41M	Buy	35,540 +3,330	+10%	+$37.2K	﹤0.01%	2440
2016 Q2	$405K	Buy	32,210 +24,147	+299%	+$225K	﹤0.01%	3153
2016 Q1	$66K	Buy	8,063 +247	+3%	+$1.86K	﹤0.01%	3258
2015 Q4	$79K	Buy	7,816 +113	+1%	+$1.17K	﹤0.01%	3292
2015 Q3	$74K	Sell	7,703 -109	-1%	-$1.53K	﹤0.01%	3321
2015 Q2	$135K	Buy	7,812 +3,035	+64%	+$44.4K	﹤0.01%	3300
2015 Q1	$52K	Hold	4,777	–	–	﹤0.01%	3325
2014 Q4	$39K	Hold	4,777	–	–	﹤0.01%	3373
2014 Q3	$49K	Sell	4,777 -5	-0.1%	-$99	﹤0.01%	3327
2014 Q2	$292K	Buy	+4,782	New	+$291K	﹤0.01%	3197

BlackRock Investment Management's TBRA Position: Q4 2016 in Review

BlackRock Investment Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 35,540 shares — an estimated $1.41M sold.

BlackRock Investment Management first reported a position in TBRA in Q2 2014 and held it in 10 quarters. The position peaked at $1.41M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

BlackRock Investment Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
BlackRock Investment Management sold 35,540 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $1.41M.
BlackRock Investment Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 10 quarters.
BlackRock Investment Management's Tobira Therapeutics, Inc. Common Stock position peaked at $1.41M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.